Tony James family office invests in Augmodo’s $37.5M Series A

Augmodo, a Seattle-based startup pioneering the use of spatial AI in retail, has closed a $37.5 million Series A funding round to scale its SmartBadge™-powered platform. The round was led by TQ Ventures and included participation from new and existing investors alike. Among the notable new backers is Jefferson River Capital—the family office of billionaire Tony James, the former President and COO of Blackstone Group. Arena Holdings, the investment firm founded by ex-Tiger Global executive Feroz Dewan, also joined the round.

Augmodo’s breakthrough comes from its innovative SmartBadges™ worn by retail associates, enabling the creation of real-time 3D maps of store layouts. These wearable devices, combined with Augmodo’s SpatialView™ analytics platform, deliver high-frequency inventory tracking, task recommendations, and live shelf data—making retail operations more agile and cost-efficient. With a setup time of just 20 minutes and zero workflow disruptions, Augmodo offers an order-of-magnitude improvement over robotic and manual alternatives, reducing stockouts and increasing shelf compliance. Following the success of a pilot with Chemist Warehouse, Augmodo quickly moved from seed to Series A in under a year, signaling strong market demand and proven results.

About the Tony James family office: Jefferson River Capital

The participation of Jefferson River Capital in Augmodo’s Series A illustrates Tony James’ growing interest in high-impact technology ventures. Founded in 2016, the New York-based family office has become a strategic platform for deploying capital across private equity, tech, and healthcare innovations. Jefferson River recently seeded Madison River Capital, a spinout private equity firm led by David Wittels—its former president and long-time associate of James since their Donaldson, Lufkin & Jenrette days.

Madison River Capital, which now manages over $1 billion in assets, targets buyout opportunities in lower middle-market U.S. companies across healthcare, business services, and industrials. James was the anchor investor, contributing approximately $60 million to its flagship fund, underlining his continued commitment to hands-on investing even after stepping back from Blackstone in 2022.

Beyond Augmodo, Jefferson River Capital’s venture appetite also includes health tech plays such as Mevo, a Brazilian digital prescription platform, where it joined Matrix Partners and other strategic investors in a $19 million Series B earlier this year. These moves reflect James’ strategic pivot toward future-focused, operationally transformative businesses in both developed and emerging markets.

Picture Source: Getty Images, Unsplash+ (04.08.2025)
Article Source: Businesswire (04.08.2025)